Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Burgeon Biotechnology logo — Rediscover a revitalized you with our advanced technology, w...

Burgeon Biotechnology

Rediscover a revitalized you with our advanced technology, where innovation meets transformation.

Founded 2017 Turkey Turkey 46 employees Venture round Biotechnology, Health Care +1

General Information

Company Name Burgeon Biotechnology
Founded Year 2017
Location Turkey Turkey
Employees 46
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Venture round
Business Model B2B, D2C, B2B2C
Revenue Model Product Sales, Service Fee, Licensing
Offices as of Oct 2026
Ankara, Turkey
Social

BounceWatch is an independent company data service, not affiliated with Burgeon Biotechnology. To contact Burgeon Biotechnology, visit burgeon.me.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Burgeon Biotechnology compare?

A PDF of Burgeon Biotechnology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Burgeon Biotechnology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 28, 2026

Burgeon Biotechnology participated in the Regenerative Aesthetic Roadshow held across Istanbul and Ankara.

Regulatory Approval Oct 21, 2026

Burgeon Biotechnology demonstrates regulatory compliance with existing Instructions For Use (IFU) for products including Calhydra, REFREJ, and NOVUMA.

Get alerts when Burgeon Biotechnology shows new signals

AI Insight

Bounce Watch AI
1 month ago

Burgeon Biotechnology is strategically advancing its market position through significant product innovation and international outreach. The recent launch of Calhydra expands their portfolio with a new skin hydration solution, underscoring their commitment to R&D in medical aesthetics. Simultaneously, their participation in the ICCE 2026 Congress in Cairo highlights a proactive approach to enhancing global visibility and engaging medical professionals, potentially paving the way for further market penetration.

Signal Types
Product Launch Market Visibility International Expansion
Strategic Labels
Product Diversification Market Expansion Scientific Engagement
Next Move: Expansion
·
Impact: 8/10
·
Ideal For: Medical Aesthetics VCs — Growth Stage

About Burgeon Biotechnology

Burgeon Biotechnology, with the slogan "Rediscover a revitalized you with our advanced technology, where innovation meets transformation," is a trailblazer in the Biotechnology, Health Care, and Life Sciences sectors. Founded in 2017 under the BMT Group in Ankara, Turkey, the company is focused on pioneering advancements in the medical aesthetics field.

The dynamic R&D team at Burgeon Biotechnology is central to its success, consistently delivering innovative, high-quality solutions that prioritize safety and effectiveness. The company's approach is grounded in integrity, transparency, and a robust commitment to sustainability, fostering trust with both customers and partners.

Since its inception, Burgeon Biotechnology has been setting new standards in aesthetic care. The company last secured a Venture Round investment on 18 December 2017, backed by Diffusion Capital Partners, reflecting investor confidence in its visionary pursuits and capacity to shape the industry's future.

Business keywords: medical aesthetics, innovation, R&D, product quality, safety, effectiveness, customer trust, aesthetic care, advanced materials, human health, advanced technology, beauty enhancement

Services & Products

Development and production of dermal fillers
Anti-aging skincare solutions
Research and development in skin rejuvenation technology

Target Customers

Individuals seeking anti-aging treatments Consumers interested in medical aesthetics Healthcare providers specializing in dermatology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Diffusion Capital Partners
Diffusion Capital Partners
18 Dec 2017

Burgeon Biotechnology Alternatives & Competitors

View All Alternatives
Burgeon Biotechnology vs
Silk Therapeutics, Inc.
Silk Therapeutics, Inc. United States

Intensive Vitamin C Treatment to Diminish Wrinkles

Series B
3 employees
Biopharma, Biotechnology
Compare Burgeon Biotechnology vs Silk Therapeutics, Inc.
Burgeon Biotechnology vs
Merz Aesthetics
Merz Aesthetics United States

We exist to fuel confidence by helping people look better, feel better and live better.

3201 employees
Biotechnology, Health Care
Compare Burgeon Biotechnology vs Merz Aesthetics
Burgeon Biotechnology vs
Uute Scientific
Uute Scientific Finland

Life without immune-mediated diseases

Convertible Note
12 employees
Biotechnology, Health Care
View all alternatives

FAQ About Burgeon Biotechnology

Rediscover a revitalized you with our advanced technology, where innovation meets transformation.
Burgeon Biotechnology was founded in 2017.
Burgeon Biotechnology is headquartered in Turkey. As of Oct 2026, it also has offices in Ankara, Turkey.
Burgeon Biotechnology operates in Biotechnology, Health Care and Life Sciences. Its work centres on medical aesthetics, innovation, R&D and product quality. Its customers include Individuals seeking anti-aging treatments, Consumers interested in medical aesthetics and Healthcare providers specializing in dermatology.
Burgeon Biotechnology has a B2B, D2C and B2B2C business model. Its revenue comes from Product Sales, Service Fee and Licensing.
Burgeon Biotechnology has approximately 46 employees.
Burgeon Biotechnology has completed 1 funding round. The latest funding stage is Venture round.
Burgeon Biotechnology offers: Development and production of dermal fillers, Anti-aging skincare solutions, Research and development in skin rejuvenation technology.
Top alternatives and competitors to Burgeon Biotechnology include Silk Therapeutics, Inc., Merz Aesthetics, Uute Scientific, EndyMed Medical, Japet Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Burgeon Biotechnology and Silk Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Burgeon Biotechnology, https://bouncewatch.com/company/burgeon, updated 10 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes